These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25347578)

  • 1. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients.
    Tiffin-Richards FE; Costa AS; Holschbach B; Frank RD; Vassiliadou A; Krüger T; Kuckuck K; Gross T; Eitner F; Floege J; Schulz JB; Reetz K
    PLoS One; 2014; 9(10):e106700. PubMed ID: 25347578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis.
    Tian R; Guo Y; Ye P; Zhang C; Luo Y
    PLoS One; 2020; 15(1):e0227073. PubMed ID: 31917792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms.
    Lee SH; Cho A; Min YK; Lee YK; Jung S
    Ren Fail; 2018 Nov; 40(1):323-330. PubMed ID: 29633885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.
    Ringkøbing SP; Larsen IU; Jørgensen K; Vinther-Jensen T; Vogel A
    J Huntingtons Dis; 2020; 9(1):59-68. PubMed ID: 31658065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for mild cognitive impairment in patients with heart failure: Montreal cognitive assessment versus mini mental state exam.
    Cameron J; Worrall-Carter L; Page K; Stewart S; Ski CF
    Eur J Cardiovasc Nurs; 2013 Jun; 12(3):252-60. PubMed ID: 22514141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.
    Fu C; Jin X; Chen B; Xue F; Niu H; Guo R; Chen Z; Zheng H; Wang L; Zhang Y
    Geriatr Gerontol Int; 2017 Dec; 17(12):2329-2335. PubMed ID: 28675607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
    Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
    Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cognition in hemodialysis patients: The Montreal Cognitive Assessment (MoCA) and important clues for testing
.
    Erken E; Altunoren O; Senel ME; Tuncel D; Yilmaz T; Ganidagli SE; Demircioglu D; Gungor O
    Clin Nephrol; 2019 May; 91(5):275-283. PubMed ID: 30686287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?
    Larner AJ
    Int Psychogeriatr; 2012 Mar; 24(3):391-6. PubMed ID: 22014176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia.
    Dong Y; Lee WY; Basri NA; Collinson SL; Merchant RA; Venketasubramanian N; Chen CL
    Int Psychogeriatr; 2012 Nov; 24(11):1749-55. PubMed ID: 22687278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening.
    Angermann S; Baumann M; Steubl D; Lorenz G; Hauser C; Suttmann Y; Reichelt AL; Satanovskij R; Sonntag F; Heemann U; Grimmer T; Schmaderer C
    PLoS One; 2017; 12(10):e0184589. PubMed ID: 29016605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.